| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Capnia, Inc. | 943,858 | 113,000 | 0.03% | ||
| 2 | REVANCE THERAPEUTICS INC COM | 77,373 | 1,609,000 | 0.47% | ||
| 3 | Sunesis Pharmaceuticals, Inc. | 500,000 | 2,050,000 | 0.60% | ||
| 4 | DYNAVAX TECHNOLOGIES CORP | 359,828 | 2,141,000 | 0.63% | ||
| 5 | KALVISTA PHARMACEUTICALS INC | 300,325 | 2,346,000 | 0.69% | ||
| 6 | REGENXBIO INC COM | 164,403 | 3,173,000 | 0.93% | ||
| 7 | CRISPR THERAPEUTICS AG | 148,878 | 3,241,000 | 0.95% | ||
| 8 | Sierra Oncology Inc. | 2,438,270 | 3,731,000 | 1.10% | ||
| 9 | FOAMIX PHARMACEUTICALS LTD | 855,000 | 4,232,000 | 1.24% | ||
| 10 | AURINIA PHARMACEUTICALS INC | 600,000 | 4,404,000 | 1.30% | ||
| 11 | Agile Therapeutics, Inc. | 1,513,975 | 4,852,000 | 1.43% | ||
| 12 | AKARI THERAPEUTICS PLC | 527,842 | 5,843,000 | 1.72% | ||
| 13 | TREVENA INC | 1,728,000 | 6,342,000 | 1.87% | ||
| 14 | BioPharmX Corporation | 12,814,286 | 6,471,000 | 1.90% | ||
| 15 | Capnia, Inc. | 14,695,264 | 10,434,000 | 3.07% | ||
| 16 | Strongbridge Biopharma plc | 3,000,000 | 14,250,000 | 4.19% | ||
| 17 | AIMMUNE THERAPEUTICS INC COM | 763,009 | 16,580,000 | 4.88% | ||
| 18 | ADVANCED ACCELERATOR APPLIC | 483,786 | 19,284,000 | 5.67% | ||
| 19 | EIGER BIOPHARMACEUTICALS INC | 1,787,091 | 20,462,000 | 6.02% | ||
| 20 | Codexis Inc Com | 5,294,825 | 25,415,000 | 7.48% | ||
| 21 | ADR - Nabriva Therapeutics AG- Usd | 4,021,559 | 48,259,000 | 14.20% | ||
| 22 | Ascendis Pharma | 1,766,832 | 49,471,000 | 14.55% | ||
| 23 | ACLARIS THERAPEUTICS INC COM | 2,858,569 | 85,243,000 | 25.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-17-003338, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
